John Carethers has officially reported his ownership of shares in AbbVie Inc. through a recent Form 3 filing. This update is noteworthy as it underscores his role as a director at the pharmaceutical giant and reflects the ongoing regulatory compliance within the industry.

Carethers, who is based in Radnor, Pennsylvania, is associated with AbbVie Inc., a prominent player in the pharmaceutical preparations sector. AbbVie operates under the ticker symbol ABBV and is incorporated in Delaware. The company has a fiscal year that ends on December 31.

The filing, dated October 23, 2026, indicates that Carethers holds one share of AbbVie Inc. The document specifies that he is a director but does not indicate any other ownership status or roles within the company.

This filing may affect various stakeholders, including AbbVie’s management team, shareholders, and regulatory bodies that monitor compliance with securities laws. The transparency of such filings is crucial for maintaining investor confidence and regulatory integrity.

The filing does not say what happens next.

Details of the Filing

The Form 3 filing was officially submitted on October 23, 2026, with a reporting period that ended on October 14, 2026. This document is part of the compliance requirements under the Securities Exchange Act of 1934, which mandates that directors, officers, and significant shareholders report their ownership and changes in ownership of the company’s securities.

Notably, the filing indicates that John Carethers holds a total of one share of AbbVie Inc. This minimal ownership may reflect a strategic decision or a symbolic gesture, as it is common for directors to hold shares to align their interests with those of shareholders.

The filing also includes a Power of Attorney, which designates several individuals as Carethers' attorneys-in-fact. This allows them to execute necessary documents related to securities filings on his behalf, ensuring compliance with SEC regulations.

Additional Context

AbbVie Inc. is incorporated in Delaware and operates primarily in the pharmaceutical preparations sector, classified under the Standard Industrial Classification code 2834. The company’s business address is located at 1 North Waukegan Road, North Chicago, IL 60064, and it has a fiscal year that concludes on December 31. The SEC filing does not provide any information regarding Carethers' future plans or intentions concerning his ownership of AbbVie shares.